Fms-like tyrosine kinase 3 is frequently overexpressed and mutated in AML patients and is a major driver in the pathogenesis of AML cancer cells (Stirewalt and Radich, 2003; Kiyoi et al, 2005). The gene discussed is FLT3; the disease is acute myeloid leukemia.